Your browser doesn't support javascript.
loading
An initial screening strategy based on epidemiologic information in esophageal cancer screening: a prospective evaluation in a community-based cancer screening cohort in rural China.
Chen, Wanqing; Li, He; Zheng, Rongshou; Ren, Jiansong; Shi, Jufang; Cao, Maomao; Sun, Dianqin; Sun, Xibin; Cao, Xiaoqin; Zhou, Jinyi; Luo, Pengfei; Wang, Jialin; Ma, Hengmin; Shao, Tiantang; Zhao, Chunling; He, Shilin; Sun, Daokuan; Xu, Yuluan; Wu, Pengli; Zeng, Hongmei; Li, Jiang; He, Jie.
Afiliação
  • Chen W; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Li H; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Zheng R; Office of Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Ren J; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Shi J; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Cao M; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Sun D; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Sun X; Department of Cancer Epidemiology, Henan Office for Cancer Control and Research, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450000, China.
  • Cao X; Department of Cancer Epidemiology, Henan Office for Cancer Control and Research, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450000, China.
  • Zhou J; Institute of Chronic Non-communicable Diseases Prevention and Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, 210009, China.
  • Luo P; Institute of Chronic Non-communicable Diseases Prevention and Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, 210009, China.
  • Wang J; Department of Public Health, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, 250117, China.
  • Ma H; Department of Public Health, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, 250117, China.
  • Shao T; Office of Chronic Non-communicable Diseases Prevention and Control, Xiping Center for Disease Control and Prevention, Zhu Madian, 463900, China.
  • Zhao C; Office of Chronic Non-communicable Diseases Prevention and Control, Xiping Center for Disease Control and Prevention, Zhu Madian, 463900, China.
  • He S; Office of Chronic Non-communicable Diseases Prevention and Control, Jinhu Center for Disease Control and Prevention, Huai'an, 211600, China.
  • Sun D; Office of Chronic Non-communicable Diseases Prevention and Control, Jinhu Center for Disease Control and Prevention, Huai'an, 211600, China.
  • Xu Y; Office of Chronic Non-communicable Diseases Prevention and Control, Tengzhou Center for Disease Control and Prevention, Tengzhou, 277599, China.
  • Wu P; Office of Chronic Non-communicable Diseases Prevention and Control, Tengzhou Center for Disease Control and Prevention, Tengzhou, 277599, China.
  • Zeng H; Office of Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Li J; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • He J; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Gastrointest Endosc ; 93(1): 110-118.e2, 2021 01.
Article em En | MEDLINE | ID: mdl-32504698
BACKGROUND AND AIMS: In China, regional organized esophageal cancer screening programs have been implemented since 2005. However, the implementation of these screening programs is still facing some urgent challenges, especially concerning identifying high-risk individuals. This study aimed to evaluate the risk stratification potential of the current initial assessment strategy used in a mass esophageal squamous cell carcinoma (ESCC) screening program in China. METHODS: A total of 43,875 participants without a previous cancer history enrolled in a mass ESCC screening program in China from 2007 to 2010 who had initial assessment results were included in this study and were followed until December 31, 2015. Eight potential risk factors for ESCC were evaluated in the initial assessment strategy. A comprehensive evaluation of the association of the initial assessment results with ESCC risk was performed by propensity score matching and Cox regression analysis. RESULTS: During a median follow-up of 5.5 years, 272 individuals developed ESCC. The high-risk population assessed at baseline had a higher risk of ESCC than the non-high-risk population, with a hazard ratio (HR) of 3.11 (95% confidence interval (CI), 2.33-4.14) after adjustment for sex, age, education level, income level, and body mass index. In addition, the initial assessment results of the high-risk population were significantly associated with the risk of all esophageal cancers (HR, 3.30; 95% CI, 2.51-4.33) and upper gastrointestinal cancers (HR, 3.03; 95% CI, 2.43-3.76). CONCLUSIONS: The initial screening tool in a mass ESCC screening program in China, consisting of 8 accessible variables in epidemiologic surveys, could be helpful for the selection of asymptomatic individuals for priority ESCC screening.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Gastrointest Endosc Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Gastrointest Endosc Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China